{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:08:13Z","timestamp":1749046093075,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13365-022-01103-1","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T20:11:45Z","timestamp":1667938305000},"page":"116-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-568X","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Baena-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rodr\u00edguez-Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Beltr\u00e1n-Corbellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Cort\u00e9s-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"De la Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cd\u00f1igo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"1103_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.coviro.2020.02.005","volume":"40","author":"ES Beck","year":"2020","unstructured":"Beck ES, Cortese I (2020) Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy. Curr Opin Virol 40:19\u201327. https:\/\/doi.org\/10.1016\/j.coviro.2020.02.005","journal-title":"Curr Opin Virol"},{"key":"1103_CR2","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, Bartt R, Major EO, Nath A (2013) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80:1430\u20131438. https:\/\/doi.org\/10.1212\/WNL.0b013e31828c2fa1","journal-title":"Neurology"},{"key":"1103_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","volume":"4","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z, Duda P (2013) A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 4:351\u2013358. https:\/\/doi.org\/10.1007\/s13365-013-0173-y","journal-title":"J Neurovirol"},{"issue":"17","key":"1103_CR4","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","volume":"380","author":"I Cortese","year":"2019","unstructured":"Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, Beck E, Reoma LB, Jacobson S, Reich DS, Nath A (2019) Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 380(17):1597\u20131605. https:\/\/doi.org\/10.1056\/NEJMoa1815039","journal-title":"N Engl J Med"},{"issue":"1","key":"1103_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17(1):37\u201351. https:\/\/doi.org\/10.1038\/s41582-020-00427-y","journal-title":"Nat Rev Neurol"},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0166-0934(99)00095-6","volume":"82","author":"CG Fedele","year":"1999","unstructured":"Fedele CG, Ciardi M, Delia S, Echevarr\u00eda JM, Tenorio A (1999) Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples. J Virol Methods 82:137\u2013144","journal-title":"J Virol Methods"},{"key":"1103_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568081","volume":"10","author":"T Kubiatowski","year":"2020","unstructured":"Kubiatowski T, Nico\u015b M, Krawczyk P (2020) Lung cancer immunotherapy in transplant patients and in patients with autoimmune diseases. Front Oncol 10:568081. https:\/\/doi.org\/10.3389\/fonc.2020.568081","journal-title":"Front Oncol"},{"issue":"11","key":"1103_CR8","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1111\/ene.15021","volume":"28","author":"N Lambert","year":"2021","unstructured":"Lambert N, El Moussaoui M, Maquet P (2021) Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: identifying relevant outcome factors. Eur J Neurol 28(11):3814\u20133819. https:\/\/doi.org\/10.1111\/ene.15021","journal-title":"Eur J Neurol"},{"issue":"11","key":"1103_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/09612033211035443","volume":"30","author":"TY Lan","year":"2021","unstructured":"Lan TY, Chen YS, Cheng CF, Huang ST, Shen CY, Hsu PN (2021) Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: a case report with literature review. Lupus 30(11):1849\u20131855. https:\/\/doi.org\/10.1177\/09612033211035443","journal-title":"Lupus"},{"issue":"6","key":"1103_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000089260","volume":"26","author":"R Molina","year":"2005","unstructured":"Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M, Goike H, Lamerz R, Nap M, S\u00f6l\u00e9tormos G, Stieber P (2005) Tumor markers in breast cancer- European group on tumor markers recommendations. Tumour Biol 26(6):281\u2013293. https:\/\/doi.org\/10.1159\/000089260","journal-title":"Tumour Biol"},{"issue":"8","key":"1103_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1080\/14740338.2016.1198775","volume":"15","author":"DW Raisch","year":"2016","unstructured":"Raisch DW, Rafi JA, Chen C, Bennett CL (2016) Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA\u2019s adverse event reporting system. Expert Opin Drug Saf 15(8):1003\u20131011. https:\/\/doi.org\/10.1080\/14740338.2016.1198775","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"1103_CR12","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1007\/s00415-021-10414-y","volume":"268","author":"D Roos-Weil","year":"2021","unstructured":"Roos-Weil D, Weiss N, Guihot A, Uzunov M, Bellanger A, Eymard B, Saadoun D, Houillier C, Idbaih A, Demeret S, Deback C, Leblond V, Galanaud D, Shor N, Pourcher V (2021) Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard? J Neurol 268(7):2458\u20132465. https:\/\/doi.org\/10.1007\/s00415-021-10414-y","journal-title":"J Neurol"},{"issue":"12","key":"1103_CR13","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1158\/1078-0432.CCR-17-3452","volume":"24","author":"HS Rugo","year":"2018","unstructured":"Rugo HS, Delord JP, Im SA, Ott PA, Piha-Paul SA, Bedard PL, Sachdev J, Le Tourneau C, Van Brummelen EMJ, Varga A, Salgado R, Loi S, Saraf S, Pietrangelo D, Karantza V, Tan AR (2018) Safety and antitumor activity of pembrolizumab in patients with estrogen receptor-positive\/human epidermal growth factor receptor 2-negative advanced breast cancer. Clin Cancer Res 24(12):2804\u20132811. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3452","journal-title":"Clin Cancer Res"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-022-01103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-022-01103-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-022-01103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T14:56:05Z","timestamp":1681224965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-022-01103-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1007\/s13365-022-01103-1","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"8 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}